Untargeted metabolomics reveals the role of AQP9 in nonalcoholic fatty liver disease in a mice model
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Untargeted metabolomics reveals the role of AQP9 in nonalcoholic fatty liver disease in a mice model
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 219, Issue -, Pages 864-875
Publisher
Elsevier BV
Online
2022-08-10
DOI
10.1016/j.ijbiomac.2022.08.023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triglycerides in Nonalcoholic Fatty Liver Disease: Guilty Until Proven Innocent
- (2021) Ivana Semova et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice
- (2021) Thuy T.P. Nguyen et al. MOLECULAR CELL
- Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
- (2021) Daniel Ferguson et al. Nature Reviews Endocrinology
- Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
- (2021) Mojgan Masoodi et al. Nature Reviews Gastroenterology & Hepatology
- Aquaporin 9 Represents a Novel Target of Chronic Liver Injury That May Antagonize Its Progression by Reducing Lipotoxicity
- (2021) Quancheng Cheng et al. Oxidative Medicine and Cellular Longevity
- The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD
- (2021) Ting Hong et al. Oxidative Medicine and Cellular Longevity
- Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review
- (2021) Cristina Piras et al. Metabolites
- Epidemiological feature of NAFLD from 1999 to 2018 in China
- (2020) Jianghua Zhou et al. HEPATOLOGY
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
- (2020) Hideki Fujii et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
- (2020) Daniela Maria Tanase et al. Journal of Diabetes Research
- TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation
- (2020) Hee-Seon Park et al. Autophagy
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Triggering and resolution of inflammation in NASH
- (2018) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- Molecular pathways of nonalcoholic fatty liver disease development and progression
- (2018) Fernando Bessone et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
- (2017) Mikhaïl Van Herck et al. Nutrients
- Metabolomics: beyond biomarkers and towards mechanisms
- (2016) Caroline H. Johnson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Hepatic AQP9 expression in male rats is reduced in response to PPARα agonist treatment
- (2015) Janne Lebeck et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice
- (2015) Amaia Rodríguez et al. Scientific Reports
- Metabolic impact of the glycerol channels AQP7 and AQP9 in adipose tissue and liver
- (2014) Janne Lebeck JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Knockdown of hepatic aquaglyceroporin-9 alleviates high fat diet-induced non-alcoholic fatty liver disease in rats
- (2013) Can Cai et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Aquaporin-9 downregulation prevents steatosis in oleic acid-induced non-alcoholic fatty liver disease cell models
- (2013) CHUAN WANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Liver Glycerol Permeability and Aquaporin-9 Are Dysregulated in a Murine Model of Non-Alcoholic Fatty Liver Disease
- (2013) Patrizia Gena et al. PLoS One
- PPARgamma activators stimulate aquaporin 3 expression in keratinocytes/epidermis
- (2011) Yan J. Jiang et al. EXPERIMENTAL DERMATOLOGY
- Altered expression and distribution of aquaporin-9 in the liver of rat with obstructive extrahepatic cholestasis
- (2008) Giuseppe Calamita et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search